Colin John Meyer bought RETA once, on Jun 1, 2016
Chief Innovation Officer at Reata Pharmaceuticals Inc
SEC CIK 0001662392 · Filings on SEC.gov ↗
$110KBought
$26.4MSold
Jun 2Last buy
Colin John Meyer's record
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Every filing
8 filings since Jun 2016, newest first
RETASell
Reata Pharmaceuticals Inc
Chief Innovation Officer
$463K−3.0%Aug 17
RETASell
Reata Pharmaceuticals Inc
Chief Innovation Officer
$527K−7.0%May 17
RETASell
Reata Pharmaceuticals Inc
Chief Innovation Officer
$53K−1.0%Mar 8
RETASell
Reata Pharmaceuticals Inc
Chief Innovation Officer
$8.1M−52.0%Mar 6
RETASell
Reata Pharmaceuticals Inc
Chief Research Officer
$8.6M−78.0%Jun 16
RETASell
Reata Pharmaceuticals Inc
Chief Research Officer
$4.2M−26.0%Nov 18
RETASell
Reata Pharmaceuticals Inc
Chief Research Officer
$4.4M−26.0%Nov 10
RETABuy
Reata Pharmaceuticals Inc
Insider
$110K+98.0%Jun 2
Filings come from SEC EDGAR. Not investment advice.